DGX - Quest Diagnostics, Inc.
SNP 500


Strong Growth and ImprovingStock Price Attractive


based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 68.9%
Operating Income Growth is 71.54%
Net Income Growth is 97.64%
Earnings Per Share (EPS) Growth is 105.81%
Net Margin is 19.72%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.62
Debt Ratio is 0.19
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.3
Cash Flow is STRONG
Cash from Operations Growth is 26.55%
Capital Expenditure is Low
Net Increase in Cash is Negative
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Quest Diagnostics, Inc. (DGX) -
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Industry - Dental Laboratories
Sector - Manufacturing
CEO - Stephen Rusckowski
Employees - 44,500

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.